Vanguard Global Advisers’s Neuronetics STIM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$38.5K Hold
16,453
– – ﹤0.01% 3149
2026
Q2
$21.4K Hold
16,453
– – ﹤0.01% 3308
2026
Q1
$23.9K Buy
+16,453
New +$26.1K ﹤0.01% 3256

Other funds holding STIM

Vanguard Global Advisers's STIM Position: Q3 2026 in Review

Vanguard Global Advisers held its Neuronetics (STIM) position steady in Q3 2026 at 16,453 shares worth $38.5K. The position accounts for ﹤0.01% of the portfolio, ranked #3149.

Vanguard Global Advisers first reported a position in STIM in Q1 2026 and has held it in 3 quarters since. 95 funds tracked by Wall St. Rank hold STIM as of Q3 2026.

  • Vanguard Global Advisers held 16,453 shares of Neuronetics worth $38.5K as of Q3 2026.
  • Vanguard Global Advisers left its Neuronetics share count unchanged in Q3 2026.
  • Neuronetics made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q3 2026, its #3149 holding.
  • Vanguard Global Advisers first reported a position in Neuronetics in Q1 2026 and has held it in 3 quarters since.
  • 95 funds tracked by Wall St. Rank held Neuronetics as of Q3 2026.

Based on Vanguard Global Advisers's 13F filing for Q3 2026, filed 13 Nov 2026.